Sunshine Biopharma Inc. (SBFM) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sunshine Biopharma Inc.

    NASDAQ: SBFM · Real-Time Price · USD
    1.53
    0.02 (1.32%)
    At close: Oct 03, 2025, 3:59 PM
    1.52
    -0.58%
    After-hours: Oct 03, 2025, 07:19 PM EDT

    Sunshine Biopharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 9.69M 16.29M 21.83M 2.05M
    Short-Term Investments
    		 n/a n/a n/a 7.59K
    Long-Term Investments
    		 n/a n/a 1.63M n/a
    Other Long-Term Assets
    		 n/a n/a -1.93M -7.06K
    Receivables
    		 3.87M 2.55M 1.91M 7.8K
    Inventory
    		 11.28M 5.73M 3.29M 105.65K
    Other Current Assets
    		 n/a n/a n/a 7.59K
    Total Current Assets
    		 25.97M 24.89M 27.31M 2.2M
    Property-Plant & Equipment
    		 1.48M 1.01M 1.15M 7.06K
    Goodwill & Intangibles
    		 3.02M 1.44M 776.86K n/a
    Total Long-Term Assets
    		 4.59M 2.46M 1.93M 7.06K
    Total Assets
    		 30.56M 27.35M 29.24M 2.2M
    Account Payables
    		 5.54M 2.59M 2.8M 42.94K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a 3.63M n/a
    Other Current Liabilities
    		 295.8K 2.55M n/a n/a
    Total Current Liabilities
    		 6.31M 5.55M 6.93M 91.23K
    Long-Term Debt
    		 n/a n/a n/a 1.9M
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 744.72K 587.76K 685.26K 1.9M
    Total Liabilities
    		 7.06M 6.14M 7.62M 1.99M
    Total Debt
    		 952.48K 657.71K 4.27M 1.9M
    Book Value
    		 23.5M 21.21M 21.63M 211.66K
    Book Value Per Share
    		 33.49 1.74K 2.85K 162.07
    Common Stock
    		 2.58K 28.02K 22.59K 2.59K
    Retained Earnings
    		 -69.04M -63.91M -59.4M -32.66M
    Comprehensive Income
    		 -829.96K 696.11K 161.85K -23.14K
    Shareholders Equity
    		 23.5M 21.21M 21.63M 211.66K
    Total Investments
    		 n/a n/a 1.63M 7.59K

    Add to Watchlist